Share Name Share Symbol Market Type Share ISIN Share Description
Beximco Pharma LSE:BXP London Ordinary Share US0885792061 GDR (EACH REPR 1 ORD BDT10)(REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.50p -5.26% 63.00p 61.00p 65.00p 66.50p 63.00p 66.50p 69,958 13:25:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 112.5 20.3 4.4 13.0 243.33

Beximco Pharma Share Discussion Threads

Showing 1476 to 1499 of 1500 messages
Chat Pages: 60  59  58  57  56  55  54  53  52  51  50  49  Older
DateSubjectAuthorDiscuss
03/8/2017
00:23
$30m market is pathetic...
zcaprd7
25/7/2017
10:26
confirmation RNS for 4th drug today. 'along with our growing pipeline' suggests more approvals to come IMHO.
mfhmfh
24/7/2017
21:42
Drug no. 4 approved by FDA, no RNS.
cockneytrader
12/7/2017
11:43
I am very happy with this one i have the main part of this stock and i don't trade and i keep topping up when go to 54 and sell almost all i topped up every time get to 63 keep the profit in share so far as worked quite few times
jovi1
28/6/2017
09:41
Some actual news not just reports, there must be some fairly big ticket events happening that would be news worthy but they've released sweet FA for 6 months other than results. There needs to be something to get excited about to make it a worth while investment and they are giving us nothing hence the waning shareprice.
ginko3
28/6/2017
00:01
They report quarterly, what more do you want?
crazycoops
27/6/2017
13:17
Its now been 6 months since any real news wtf is BXP doing, no wonder the share price performance is so lacklustre this year
ginko3
20/6/2017
12:36
Would hope to get confirmation shortly that they've launched the Metformin / Glucophage tablets through their distributor in the US and shortly thereafter, some indication of the level of take-up.
ginko3
17/6/2017
14:06
I'm also back in now albeit in a small way, didn't quite catch the bottom but in for 60p for just about in profit now; quite happy and able to sit it out for the long term.
ginko3
17/6/2017
00:19
Good shout... Keeping my powder dry at the moment though.
zcaprd7
15/6/2017
18:17
Couldn't believe 54p to BUY. So I'm back in here now. 50% discount??? - when there's been agitation for dividend payments to GDR holders? If they go ahead, we'll get one of the highest yields in the market. (about 12% here) Ave discount anyway over the past year has been under 40% (which is too much IMHO anyway). And the co is world class, so over time it's going higher. The mkt is certainly daft at times - delighted in this case! J
jswjsw
15/6/2017
17:07
I bought in here on the dip. I've been waiting ages for a good entry price. great long-term ISA hold IMHO. GL all.
mfhmfh
15/6/2017
16:30
no idea but I used to average down and pick up few at 53 and 54 the odd thing was that drop 10 point on a 37k share traded
jovi1
15/6/2017
15:56
Whoa! what just happened there? Minus 10p from nowhere
crazycoops
09/5/2017
13:56
I'm sittin and waiting... big rise coming over the next 2 years... also buyout possibility so 0% discount to dhaka, plus more big paying drugs will be in the pipeline £2-£5 in next 2-3 years with very little risk. GLA
greg the grinch
02/5/2017
08:51
Agreed. Decided to lock in my 70% gain. Will probably regret...
zcaprd7
01/5/2017
19:01
Based on the eps figure and historic prices, BXP is fair at BDT 103-108 (around £1 equivalent). 69p may seem like a big discount, but this has been around 45% for long periods. Over the past week or so this has narrowed to just over 30%, where it is probably fair, IMHO. Can't see the £ strengthening much more, but I worry slightly that Dhaka is retracing. So I sold on Fri - will buy back if we see BDT 100. j
jswjsw
01/5/2017
18:20
Top-line growth and profit look OK but my concern would be that the company is not generating any FCF and hasn't consistently done so. Why are they paying a dividend if they are still investing so heavily in growth? BTW: look at their accounts on the website not the numbers on Stockopedia. (running down short-term investments doesn't count as FCF!) Doesn't mean it is a bad company but it pays to understand what is going on..
jombaston
29/4/2017
21:40
Figures look decent enough to me. A pity that the company provides figures and no real commentary on current trading or outlook. Certainly not a company that can be accused of over hyping it's prospects to investors! No negatives from Graham Neary and as he points out BXP has a very high stock rank on Stockopedia. I'm happy to keep running a long position here. Dibbs
dibbs
28/4/2017
14:08
there is a brief write up in today's SCVR by Graham Neary http://www.stockopedia.com/content/small-cap-value-report-28-april-2017-kmk-je-bxp-trak-181779/
crazycoops
28/4/2017
09:59
Yes - I couldn't make much sense of it. Too many numbers. Maybe the final results will make things clearer.
someuwin
28/4/2017
09:49
Looks good. Hard to get an understanding of future of growth though?
zcaprd7
28/4/2017
08:05
Pre tax profit up 20%
someuwin
27/4/2017
10:52
£1+ this year is my prediction.
someuwin
Chat Pages: 60  59  58  57  56  55  54  53  52  51  50  49  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20170821 19:41:34